SANUWAVE Health, Inc. (NASDAQ:SNWV) Director Anthony Michael Stolarski bought 500,000 shares of the company’s stock in a transaction on Wednesday, September 28th. The stock was purchased at an average cost of $0.06 per share, for a total transaction of $30,000.00. Following the completion of the transaction, the director now directly owns 3,724,626 shares of the company’s stock, valued at approximately $223,477.56. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
SANUWAVE Health, Inc. (NASDAQ:SNWV) opened at 0.15 on Monday. SANUWAVE Health, Inc. has a 12 month low of $0.03 and a 12 month high of $0.17. The firm has a 50-day moving average price of $0.13 and a 200 day moving average price of $0.07. The stock’s market capitalization is $15.75 million.
About SANUWAVE Health
SANUWAVE Health, Inc is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
Receive News & Ratings for SANUWAVE Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SANUWAVE Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.